These findings align with reports that AVN-C preserves cognitive function by inhibiting NF-κB-mediated cytokine release, a mechanism also relevant to Alzheimer’s disease pathology (Nathan et al., 2025). This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.